These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2349879)

  • 1. Acylcarnitine is low in cord blood in cystic fibrosis.
    Lloyd-Still JD; Bohan T; Hughes S; Wessel HU
    Acta Paediatr Scand; 1990 Apr; 79(4):427-30. PubMed ID: 2349879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carnitine metabolites in infants with cystic fibrosis: a prospective study.
    Lloyd-Still JD; Powers CA; Wessel HU
    Acta Paediatr; 1993 Feb; 82(2):145-9. PubMed ID: 8477159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carnitine metabolites in infants with cystic fibrosis.
    Lloyd-Still JD; Powers C
    Acta Univ Carol Med (Praha); 1990; 36(1-4):78-80. PubMed ID: 2130727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perinatal Reduced Blood Concentrations of Free Carnitine and Acylcarnitines in Infants with Cystic Fibrosis.
    Schulpis KH; Molou E; Manta-Vogli P; Dotsikas Y; Thodi G; Chatzidaki M; Loukas YL
    Am J Perinatol; 2021 Jul; 38(8):828-833. PubMed ID: 31891954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential fatty acid status and fluidity of plasma phospholipids in cystic fibrosis infants.
    Lloyd-Still JD; Johnson SB; Holman RT
    Am J Clin Nutr; 1991 Dec; 54(6):1029-35. PubMed ID: 1957818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma carnitine levels in cystic fibrosis.
    Kovesi TA; Lehotay DC; Levison H
    J Pediatr Gastroenterol Nutr; 1994 Nov; 19(4):421-4. PubMed ID: 7876997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy-related changes of carnitine and acylcarnitine concentrations of plasma and erythrocytes.
    Schoderbeck M; Auer B; Legenstein E; Genger H; Sevelda P; Salzer H; Marz R; Lohninger A
    J Perinat Med; 1995; 23(6):477-85. PubMed ID: 8904477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum metabolomics indicate altered cellular energy metabolism in children with cystic fibrosis.
    Joseloff E; Sha W; Bell SC; Wetmore DR; Lawton KA; Milburn MV; Ryals JA; Guo L; Muhlebach MS
    Pediatr Pulmonol; 2014 May; 49(5):463-72. PubMed ID: 23847148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postnatal changes in neonatal acylcarnitine profile.
    Meyburg J; Schulze A; Kohlmueller D; Linderkamp O; Mayatepek E
    Pediatr Res; 2001 Jan; 49(1):125-9. PubMed ID: 11134502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human forearm arteriovenous differences of carnitine, short-chain acylcarnitine and long-chain acylcarnitine.
    Bartlett K; Bhuiyan AK; Aynsley-Green A; Butler PC; Alberti KG
    Clin Sci (Lond); 1989 Oct; 77(4):413-6. PubMed ID: 2805599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter: Essential-fatty-acid metabolism in cystic fibrosis.
    Watts R; Taylor S; Postuma R; Smalley CA
    Lancet; 1975 Nov; 2(7942):983. PubMed ID: 53469
    [No Abstract]   [Full Text] [Related]  

  • 12. Maternal, cord, and neonatal carnitine correlations and lipid profiles of various birthweight infants.
    Sachan DS; Smith RB; Plattsmier J; Lorch V
    Am J Perinatol; 1989 Jan; 6(1):14-7. PubMed ID: 2910313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carnitine in the perinatal metabolism of lipids. I. Relationship between maternal and fetal plasma levels of carnitine and acylcarnitines.
    Novak M; Monkus EF; Chung D; Buch M
    Pediatrics; 1981 Jan; 67(1):95-100. PubMed ID: 7243438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carnitine-acylcarnitine translocase deficiency: metabolic consequences of an impaired mitochondrial carnitine cycle.
    Röschinger W; Muntau AC; Duran M; Dorland L; IJlst L; Wanders RJ; Roscher AA
    Clin Chim Acta; 2000 Aug; 298(1-2):55-68. PubMed ID: 10876004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carnitine content of blood and amniotic fluid.
    Hahn P; Skala JP; Seccombe DW; Frohlich J; Penn-Walker D; Novak M; Hynie I; Towell ME
    Pediatr Res; 1977 Aug; 11(8):878-80. PubMed ID: 887305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related variations in acylcarnitine and free carnitine concentrations measured by tandem mass spectrometry.
    Cavedon CT; Bourdoux P; Mertens K; Van Thi HV; Herremans N; de Laet C; Goyens P
    Clin Chem; 2005 Apr; 51(4):745-52. PubMed ID: 15708951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive test using palmitate in patients with suspected fatty acid oxidation defects: disease-specific acylcarnitine patterns can help to establish the diagnosis.
    Janzen N; Hofmann AD; Schmidt G; Das AM; Illsinger S
    Orphanet J Rare Dis; 2017 Dec; 12(1):187. PubMed ID: 29268767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carnitine plasma concentrations in 353 metabolically healthy children.
    Schmidt-Sommerfeld E; Werner D; Penn D
    Eur J Pediatr; 1988 May; 147(4):356-60. PubMed ID: 3396591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carnitine level and several lipid parameters in venous blood of newborns, cord blood and maternal blood and milk.
    Hromadová M; Parrák V; Huttová M; Danová K; Urvölgyová M
    Endocr Regul; 1994 Mar; 28(1):47-52. PubMed ID: 7949014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effect of exercise training on cardiac long-chain acylcarnitine levels in diabetic rats.
    Broderick TL; St-Laurent R; Rousseau-Migneron S; Tancrede G; Nadeau A
    Diabetes Res; 1990 Jun; 14(2):83-6. PubMed ID: 2134218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.